BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11135083)

  • 1. Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine.
    Dowling TC; Frye RF; Fraley DS; Matzke GR
    Kidney Int; 2001 Jan; 59(1):295-303. PubMed ID: 11135083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium inhibition of renal tubular p-aminohippurate transport in the rat: relation to plasma 2-oxoglutarate.
    Szczepanska-Konkel M; Sadowski J; Angielski S
    Acta Physiol Hung; 1983; 62(3-4):235-43. PubMed ID: 6666606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.
    van Olden RW; van Acker BA; Koomen GC; Krediet RT; Arisz L
    Clin Nephrol; 1998 Mar; 49(3):167-72. PubMed ID: 9543598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat.
    Weinman EJ; Frankfurt SJ; Ince A; Sansom S
    J Clin Invest; 1978 Mar; 61(3):801-6. PubMed ID: 641156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of simplified and standard methods for the measurement of glomerular filtration rate and renal tubular function.
    Notghi A; Merrick MV; Ferrington C; Anderton JL
    Br J Radiol; 1986 Jan; 59(697):35-9. PubMed ID: 3947805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturable urinary excretion kinetics of famotidine in the dog.
    Boom SP; Hoet S; Russel FG
    J Pharm Pharmacol; 1997 Mar; 49(3):288-92. PubMed ID: 9231347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats.
    Hasegawa T; Nadai M; Wang L; Takayama Y; Kato K; Nabeshima T; Kato N
    Drug Metab Dispos; 1994; 22(1):8-13. PubMed ID: 8149895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
    Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
    Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
    Prescott LF; Freestone S; McAuslane JA
    Br J Clin Pharmacol; 1993 Jan; 35(1):20-9. PubMed ID: 8448064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the renal handling of p-aminohippurate (PAH) in the beagle dog (Canis familiaris).
    Mann WA; Kinter LB
    Gen Pharmacol; 1993 Mar; 24(2):367-72. PubMed ID: 8482521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new method for the determination of the maximal tubular transport of p-aminohippuric acid without urine analysis in children with transplanted kidney].
    Devaux S; Gellert S; Streichan F
    Z Urol Nephrol; 1984 Nov; 77(11):639-46. PubMed ID: 6395558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats.
    Lin JH; Lin TH
    J Pharmacol Exp Ther; 1988 Sep; 246(3):896-901. PubMed ID: 3418518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splanchnicotomy on the renal excretion of para-aminohippuric acid in the anaesthetized dog.
    Szalay L; Bencsáth P; Takács L
    Pflugers Arch; 1977 Jan; 367(3):287-90. PubMed ID: 556852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of renal p-aminohippurate and urate excretion in rabbits.
    Donoso VS; Grantham JJ
    J Lab Clin Med; 1986 Apr; 107(4):315-21. PubMed ID: 3958573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tubular dysfunction in patients with cystic disease of the kidneys.
    Pabico RC; McKenna BA; Freeman RB
    Urology; 1998 May; 51(5A Suppl):156-60. PubMed ID: 9610573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of para-aminohippurate on renal transport of oxalate.
    Knight TF; Senekjian HO; Weinman EJ
    Kidney Int; 1979 Jan; 15(1):38-42. PubMed ID: 491395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal transport step of para-aminohippurate (PAH): transport from PAH-loaded proximal tubular cells into the tubular lumen of the rat kidney in vivo.
    Ullrich KJ; Rumrich G
    Pflugers Arch; 1997 Apr; 433(6):735-43. PubMed ID: 9049164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.
    Udy AA; Jarrett P; Stuart J; Lassig-Smith M; Starr T; Dunlop R; Wallis SC; Roberts JA; Lipman J
    Crit Care; 2014 Nov; 18(6):657. PubMed ID: 25432141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion kinetics of famotidine in rats.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1987; 15(2):212-6. PubMed ID: 2882981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.